High Flow Nasal Oxygen Therapy an Implementation Study in Pediatric Wards (HFNO)

Epicentre

Status: Not yet enrolling

Conditions: Severe Respiratory Distress; Moderate Respiratory Distress

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT06715423

G2429-HFNO_ProcessEvaluation

Details and patient eligibility

About

The purpose of this study is to prospectively evaluate the process of implementing HFNO in several MSF projects, varying according to geographical and programmatic contexts, population, health structures, human resources, and management. It will generate evidence on the operational feasibility (in terms of human resources, equipment, logistics and costs) of integrating HFNO into PICU standard of care, as well as on the users' and caregivers' perspectives on HFNO and on the children clinical outcomes observed where HFNO is implemented. This relevant information will guide MSF in the decision making of scaling up HFNO therapy in its projects.

Full description

Mixed method study: quantitative component for the data of the children and qualitative data for the perception for health staffs and parents

Enrollment: 960 estimated patients

Sex: All

Ages: 1 month to 5 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• prescription of HFNO by clinician
• parent consenting to the use of the data

Trial design

960 participants in 1 patient group

Pediactric ICU Hospitalized children 1mo to 5 yo

Description:

Prescription of HFNO therapy